Clinical trial

INSTI's For The Management of HIV-associated TB

NCT04734652

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-02-18

PhasePHASE2

Study timeline

Study start (actual)2022-02-18Date precision: day

Registry last updated2025-10-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV/AIDSunresolved

Tuberculosis, Pulmonaryunresolved

Interventions

Biktarvy®COMBINATION_PRODUCT

TLD- fixed-drug combination single tabletCOMBINATION_PRODUCT

Sponsors & collaborators

Centre for the AIDS Programme of Research in South Africalead sponsor

Johns Hopkins Universitycollaborator

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

University of Cape Towncollaborator

Medical Research Council, South Africacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04734652 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.